Literature DB >> 3087085

[Methodological framework of the evaluation of systematic screening and treatment of preexistent lesions of the colon and the rectum].

R Flamant, F Doyon, A Mollie.   

Abstract

Among the conditions which need to be filled when generalizing the mass screening of polyps in view of the secondary prevention of colorectal cancers, three are already present: 1) it is a frequent and serious cancer; 2) there is an affiliation between benign tumours and cancer; 3) an effective non-mutilating treatment of benign tumours is available. On the other hand, two additional conditions remain unfilled and yet lie within the domain of research by methodologically rigorous studies: the setting up of a screening test with a high cost-effectiveness relationship; the epidemiological demonstration of the decreasing incidence of colorectal cancers following screening and treatment of precancerous lesions.

Entities:  

Mesh:

Year:  1986        PMID: 3087085     DOI: 10.1007/bf02091593

Source DB:  PubMed          Journal:  Soz Praventivmed        ISSN: 0303-8408


  5 in total

1.  Screening for colorectal cancer: the issues.

Authors:  S Winawer; D Schottenfeld; P Sherlock
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

2.  The earlier detection of colorectal cancers: a preliminary report of the results of the Occult Blood Study.

Authors:  V A Gilbertsen; R McHugh; L Schuman; S E Williams
Journal:  Cancer       Date:  1980-06-01       Impact factor: 6.860

3.  Controlled trial of faecal occult blood testing in the detection of colorectal cancer.

Authors:  J D Hardcastle; P A Farrands; T W Balfour; J Chamberlain; S S Amar; M G Sheldon
Journal:  Lancet       Date:  1983-07-02       Impact factor: 79.321

4.  Progress report on controlled trial of fecal occult blood testing for the detection of colorectal neoplasia.

Authors:  S J Winawer; M Andrews; B Flehinger; P Sherlock; D Schottenfeld; D G Miller
Journal:  Cancer       Date:  1980-06-15       Impact factor: 6.860

Review 5.  Occult blood screening for colorectal carcinoma: a critical review.

Authors:  J B Simon
Journal:  Gastroenterology       Date:  1985-03       Impact factor: 22.682

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.